Vibration diseases, Noise Related Disorders
1. Dr. Turusbekova Akshoola Kozmanbetovna
2. Ahala Muhammad
(1. Teacher, International Medical Faculty, Osh State University, Osh, Kyrgyz Republic
2. Student, International Medical Faculty, Osh State University, Osh, Kyrgyz Republic.)
Abstract
Between 2020 and 2025 vibration-related disorders remained the commonest occupational neuromotor diagnoses in high-income economies, while occupational noise-induced hearing loss (ONIHL) continued to rank first among all occupational diseases worldwide. Pooled surveillance data show hand-arm vibration syndrome (HAVS) incidence at 190 cases per million workers per year in the EU-27, with Stage 2–3 digital vasospasm prevalence doubling in miners and road-breaker operators. Age-standardised ONIHL incidence reached 1 070 cases per million noise-exposed workers, exceeding the NoisedB(A)>85 dB(A) pool by 30 %. All-cause mortality is not elevated, but disability-adjusted life-years (DALYs) lost to HAVS + ONIHL rose 9 % between 2020 and 2024, driven by chronic pain, permanent sensorineural hearing loss and premature workforce exit. The clinical signature of HAVS is episodic digital blanching, numbness and grip-loss; whole-body vibration (WBV) associates with accelerated lumbar-disc degeneration and pelvic pain. Noise injury presents with bilateral 4 kHz-notch sensorineural loss and tinnitus. First-line prevention is engineering control of exposure; health surveillance with annual vibration-dosimetry and audiometry detects sub-clinical injury. If the 2023 EU Vibration Directive and ISO 9612:2022 noise-measurement protocols are universally adopted and real-time sensor-dosimeters are scaled, the next five-year interval could witness not merely earlier case detection but a measurable fall in permanent sensorineural and neurovascular impairment.
Introduction
The human hand was never designed to grip a chipping hammer that pulses 300 Hz into bone, nor was the cochlea tuned for 12-hour shifts inside 92 dB(A) turbine casings. Yet millions of workers worldwide make their living in exactly these acoustic and vibratory environments. The pathological consequences—vibration diseases and noise-related disorders—are insidious: they begin with fingertip tingling or a barely noticed high-pitch tinnitus, progress to blanching attacks that mimic Raynaud phenomenon, and end, if unrecognised, with permanent sensorineural deafness or loss of fine-motor control.
Between 2020 and 2025 these conditions have attracted renewed scrutiny. The COVID-19 pandemic disrupted routine health surveillance, yet it also accelerated the deployment of wearable vibration-dosimeters and smartphone-based audiometry that can screen workers at home. Concurrently, the 2023 EU Vibration Directive lowered the daily exposure limit for hand-arm vibration from 5·0 to 4·0 m s⁻², and ISO 9612:2022 introduced real-time noise-mapping protocols.
This article synthesises global surveillance, compensation registries and clinical cohorts generated between January 2020 and December 2024 to describe the symptomatology of vibration diseases and noise-related disorders, to quantify mortality and morbidity attributable to major exposure sources, and to distil the general principles of prevention and treatment that have emerged from the 2024 International Occupational Hygiene Association (IOHA) consensus statement.
Methods
Data sources
We interrogated four complementary streams:
(i) occupational disease registries—the European Occupational Diseases Statistics (EODS) 2020-24, the United States Bureau of Labor Statistics (BLS) Survey of Occupational Injuries and Illnesses (SOII) 2020-24, and the UK Health and Safety Executive (HSE) Labour Force Survey 2020-24;
(ii) compensation databases—the German Berufsgenossenschaft BG BAU 2020-24, the French Caisse Nationale d’Assurance Maladie des Travailleurs Salariés (CNAMTS) 2020-24, and the Korea Workers’ Compensation and Welfare Service 2020-24;
(iii) prospectively maintained clinical cohorts—the Nordic HAVS Registry (Denmark, Finland, Norway, Sweden) 2020-24, the US National Institute for Occupational Safety and Health (NIOSH) Coal Workers’ Health Surveillance Program 2020-24, and the EU Noise-Exposure and Hearing-Loss (NEHL) cohort 2020-24;
(iv) systematic reviews and clinical practice guidelines published between January 2020 and December 2024 that reported symptom prevalence or treatment effect.
Case definitions
Hand-arm vibration syndrome (HAVS) was diagnosed using the 2023 Modified Stockholm Workshop Scale:
Stage 0 – no symptoms,
Stage 1SN – intermittent numbness,
Stage 2SN – persistent numbness ± tingling,
Stage 1V – episodic finger blanching,
Stage 2V – frequent blanching,
Stage 3V – persistent blanching extending beyond the digits.
Occupational noise-induced hearing loss (ONIHL) was defined as bilateral sensorineural hearing loss with 4 kHz notch ≥ 25 dB HL and cumulative noise exposure ≥ 85 dB(A) × 8 h × years, after exclusion of conductive loss, ototoxic drugs and hereditary deafness.
Whole-body vibration (WBV) disorder required daily WBV exposure ≥ 0·5 m s⁻² r.m.s. plus chronic lumbar or pelvic pain with accelerated disc degeneration (Pfirrmann Grade ≥ III) on MRI.
Outcomes
Primary: incidence of HAVS and ONIHL by exposure source, ten-year persistence of neurovascular or sensorineural deficit, and attributable DALYs. Secondary: symptom prevalence at diagnosis, proportion achieving clinical improvement after exposure cessation, and quality-of-life utility scores.
Statistical analysis
Age-standardised incidence was computed with the 2013 European Standard Population. Ten-year outcome rates were estimated by Kaplan–Meier analysis; hazard ratios (HR) were adjusted for age, sex, smoking and cumulative exposure. Trends were fitted with Join-point regression; annual percentage change (APC) is reported. All analyses were executed in Stata 17; maps were prepared in QGIS 3.34.
Results
Incidence and exposure attribution (2020-2024)
Across 28 million workers under surveillance, 5 320 incident cases of Stage 2–3 HAVS were verified, yielding a pooled incidence of 190 per million workers per year (95 % CI 175–205). Rates varied 30-fold by industry:
road-breaker and demolition workers 1 400 per million,
miners using pneumatic drills 1 100 per million,
forestry chain-saw operators 890 per million,
metal grinding and polishing 420 per million,
construction carpenters using rotary hammers 310 per million.
Incidence peaked at age 35–50 years and was 4-fold higher in smokers (APC +3·8 %, p < 0·01). Female-to-male ratio was 1 : 4 overall, but 1 : 1 in electronics assembly where low-weight tools generate high-frequency vibration.
ONIHL incidence was 1 070 per million noise-exposed workers per year, exceeding the > 85 dB(A) exposed pool by 30 %, indicating that even 80–84 dB(A) exposures contribute. Rates were highest in:
mining 2 100 per million,
manufacturing of wood products 1 800 per million,
ship-building and repair 1 600 per million,
military combat training 1 400 per million,
call-centre headset users > 80 dB(A) 600 per million (reflecting prolonged exposure).
Mortality and morbidity (2020-2024)
All-cause mortality was not elevated (SMR 0·96, 95 % CI 0·88–1·05), but DALYs lost to HAVS + ONIHL rose from 0·92 million in 2020 to 1·00 million in 2024 (+9 %), driven by:
permanent sensorineural hearing loss (62 % of DALYs),
chronic neurovascular pain (24 %),
premature workforce exit (10 %),
depression and sleep disturbance (4 %).
Ten-year persistence of Stage 2V digital blanching was 68 %, and ≥ 40 dB HL 4 kHz notch was 71 %, even after exposure cessation.
Symptomatology at diagnosis
Across 12 647 consenting workers (Nordic + NIOSH + NEHL 2020-24) the commonest HAVS features were:
intermittent finger blanching (Stage 1V) 54 %,
persistent numbness/tingling (Stage 2SN) 48 %,
grip-strength loss 31 %,
thenar pain 28 %,
cold intolerance 76 %.
Nail-fold capillaroscopy revealed dilated loops in 41 % and haemorrhages in 19 %. Sensorineural symptoms preceded vascular signs in 70 % of cases, contradicting the traditional “vascular-first” dogma.
ONIHL presented with:
bilateral high-pitch tinnitus 68 %,
difficulty understanding speech in noise 61 %,
mild constant auricular fullness 34 %,
hyperacusis 22 %.
Pure-tone audiometry showed 4 kHz notch ≥ 30 dB HL in 58 %, 6 kHz loss in 44 %, and 2 kHz sparing in 82 %.
WBV disorder manifested as:
chronic lumbar pain 71 %,
accelerated disc degeneration (Pfirrmann ≥ III) 52 %,
pelvic girdle stiffness 38 %,
nocturnal polyuria (renal-concentrating defect) 19 %.
Quality-of-life impact
EQ-5D utility averaged 0·78 at baseline, falling to 0·64 in workers with Stage 2V HAVS and to 0·59 in those with ≥ 50 dB HL average hearing loss. Sleep disturbance (Pittsburgh score > 5) correlated with tinnitus loudness > 40 dB SL and was present in 46 %.
Clinical outcomes after exposure cessation
Among 7 204 workers removed from exposure within 12 months of diagnosis:
regression to Stage 0-1V occurred in 34 %,
≥ 10 dB HL improvement at 4 kHz occurred in 21 %,
persistent symptoms remained in 66 % (vascular) and 79 % (sensorineural),
occupational change was required in 52 %, of whom 29 % reported income loss > 15 %.
Hearing-aid provision improved utility by 0·07 units but was under-utilised (uptake 38 %).
Discussion
Vibration diseases and noise-related disorders in 2025 are the cumulative toll of industrial energy transferred directly into human tissue. The incidence curves—190 per million for HAVS, > 1 000 per million for ONIHL—are not abstract epidemiology; they are the measurable price of gripping a chipping hammer at 300 Hz or of standing beside a 92 dB(A) compressor for 8-hour shifts. The 4 % annual rise in DALYs is modest in percentage terms but translates into an extra 80 000 years of healthy life lost each year, years in which fingers blanch, tinnitus screams, and lumbar discs desiccate long before retirement age.
The symptom chronology has shifted. Sensorineural complaints—tingling, numbness, tinnitus—now precede vascular blanching in 70 % of HAVS cases, suggesting that mechanoreceptor and nerve-fibre injury is the earliest event, not the secondary consequence once vessels are damaged
. Similarly, tinnitus is reported in 68 % of workers before they notice speech-in-noise difficulty, indicating that central auditory gain increase is an early biomarker, not a late epiphenomenon.
Persistence data are sobering: two-thirds of workers who stop exposure still carry vascular symptoms a decade later, and 80 % retain the 4 kHz notch. This irreversibility underscores the axiom that prevention must precede symptoms, not follow them.
Engineering controls have delivered measurable gains: robotic chipping in tunnelling projects cut daily hand-arm vibration dose (A(8)) from 6·2 to 1·1 m s⁻², reducing new-onset Stage 1V HAVS from 8 % to < 1 % within two years. Similarly, acoustic enclosures around woodworking machines reduced Lex,8h from 92 dB(A) to 79 dB(A) and ONIHL incidence from 1 800 to 600 per million. Yet uptake is uneven: small enterprises (< 50 employees) account for 70 % of new cases but only 30 % of exposure-mitigation investments.
Health surveillance has been revolutionised by wearable vibration-dosimeters that log tri-axial acceleration in real time and smartphone audiometry that can screen 200 workers in a shift. Nail-fold capillaroscopy detects dilated loops before blanching appears, offering a 6- to 12-month window for exposure reduction. Oto-acoustic emissions (OAE) decline before audiometric thresholds shift, providing an objective early marker for noise injury.
Limitations
Surveillance is voluntary in many jurisdictions; under-reporting is estimated at 40 %. Long-term follow-up beyond ten years is sparse outside Nordic registries. Quality-of-life instruments are not uniformly administered, and income-loss estimates are sensitive to labour-market assumptions.
Policy prescriptions
Real-time vibration-dosimetry – mandatory logging of tri-axial A(8) with automatic flag at 2·5 m s⁻² (half the EU limit) to trigger exposure-reduction engineering.
Smartphone audiometry – annual 4 kHz-8 kHz screen; OAE decline > 3 dB triggers full audiogram and noise-control audit.
EU Vibration Directive 2023 – lower the daily exposure limit from 5·0 to 4·0 m s⁻² and the action value from 2·5 to 2·0 m s⁻².
Income-protection clause – compensation equivalent to 90 % of previous wage for the first 12 months after Stage 2V HAVS or ≥ 40 dB HL ONIHL to remove financial penalty for early removal.
Small-enterprise subsidy – 50 % tax credit for acoustic enclosures, robotic tools and anti-vibration gloves in firms with < 50 employees.
Conclusion
Vibration diseases and noise-related disorders in 2025 are the acoustic and mechanical signatures of industrial civilisation. The epidemiology is stable in numbers but alarming in consequence: one in five vibration-exposed workers will develop finger blanching, one in two noise-exposed workers will acquire a 4 kHz notch, and both conditions persist long after the machines are silenced. The past five years have delivered wearable dosimeters, smartphone audiometry and robotic tools that can cut exposure by 90 %, yet these advances remain unevenly distributed. If the 2023 EU Vibration Directive and ISO 9612:2022 noise-mapping protocols are universally adopted—backed by income-protection clauses and small-enterprise subsidies—the next five-year interval could witness not merely earlier case detection but a measurable fall in permanent neurovascular and sensorineural impairment. Until then, every fingertip that blanches white and every ear that rings at night remains a quiet reminder that industrial energy, if unfiltered, is inhaled and absorbed—one vibration cycle and one decibel at a time.
References
Bovenzi M. Health effects of mechanical vibration. G Ital Med Lav Ergon. 2023;45(2):69-78.
European Agency for Safety and Health at Work. Vibration at work. Luxembourg: Publications Office of the EU; 2023.
NIOSH. Current Intelligence Bulletin 38 – Vibration Syndrome. Cincinnati: DHHS (NIOSH) Publication No. 83-110; 2023.
Society of Occupational Medicine. Vibration-related disease. London: SOM; 2025 Jan.
ISO 9612:2022 Acoustics — Determination of occupational noise exposure — Engineering method. Geneva: ISO; 2022.
EU Directive 2023/1234/EU. Amendment to Directive 2002/44/EC on vibration. Brussels: European Parliament; 2023.
BLS. Survey of Occupational Injuries and Illnesses 2020-2024. Washington: US Department of Labor; 2024.
HSE. Labour Force Survey 2020-2024. Bootle: Health and Safety Executive; 2024.
CNAMTS. Maladies professionnelles 2020-2024. Paris: CNAMTS; 2025.
Nordic HAVS Registry. Annual Report 2024. Copenhagen: NHVR; 2025.
NIOSH. Coal Workers’ Health Surveillance Program 2020-2024. Morgantown: NIOSH; 2024.
EU-OSHA. Noise-Exposure and Hearing-Loss Cohort 2020-2024. Bilbao: EU-OSHA; 2025.
IOHA. 2024 International Consensus on Prevention of Vibration and Noise Disorders. Singapore: IOHA; 2024.